- Home
- IMAB vs NQP Comparison
IMAB vs NQP Comparison
Compare IMAB & NQP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- NQP
- Stock Information
- Founded
- IMAB 2014
- NQP 1990
- Country
- IMAB United States
- NQP United States
- Employees
- IMAB N/A
- NQP N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- NQP Trusts Except Educational Religious and Charitable
- Sector
- IMAB Health Care
- NQP Finance
- Exchange
- IMAB Nasdaq
- NQP Nasdaq
- Market Cap
- IMAB 384.6M
- NQP 413.9M
- IPO Year
- IMAB 2020
- NQP N/A
- Fundamental
- Price
- IMAB $3.69
- NQP $11.37
- Analyst Decision
- IMAB Strong Buy
- NQP
- Analyst Count
- IMAB 5
- NQP 0
- Target Price
- IMAB $6.80
- NQP N/A
- AVG Volume (30 Days)
- IMAB 1.7M
- NQP 58.4K
- Earning Date
- IMAB 11-02-2025
- NQP 01-01-0001
- Dividend Yield
- IMAB N/A
- NQP 3.21%
- EPS Growth
- IMAB N/A
- NQP N/A
- EPS
- IMAB N/A
- NQP N/A
- Revenue
- IMAB N/A
- NQP N/A
- Revenue This Year
- IMAB N/A
- NQP N/A
- Revenue Next Year
- IMAB N/A
- NQP N/A
- P/E Ratio
- IMAB N/A
- NQP N/A
- Revenue Growth
- IMAB N/A
- NQP N/A
- 52 Week Low
- IMAB $0.60
- NQP $9.65
- 52 Week High
- IMAB $5.90
- NQP $11.89
- Technical
- Relative Strength Index (RSI)
- IMAB 45.33
- NQP 71.48
- Support Level
- IMAB $3.20
- NQP $11.32
- Resistance Level
- IMAB $4.64
- NQP $11.46
- Average True Range (ATR)
- IMAB 0.41
- NQP 0.08
- MACD
- IMAB -0.17
- NQP 0.04
- Stochastic Oscillator
- IMAB 29.88
- NQP 86.19
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.